Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria
Abstract
Cells harbor two systems for fatty acid synthesis, one in the cytoplasm (catalyzed by fatty acid synthase, FASN) and one in the mitochondria (mtFAS). In contrast to FASN, mtFAS is poorly characterized, especially in higher eukaryotes, with the major product(s), metabolic roles, and cellular function(s) being essentially unknown. Here we show that hypomorphic mtFAS mutant mouse skeletal myoblast cell lines display a severe loss of electron transport chain (ETC) complexes and exhibit compensatory metabolic activities including reductive carboxylation. This effect on ETC complexes appears to be independent of protein lipoylation, the best characterized function of mtFAS, as mutants lacking lipoylation have an intact ETC. Finally, mtFAS impairment blocks the differentiation of skeletal myoblasts in vitro. Together, these data suggest that ETC activity in mammals is profoundly controlled by mtFAS function, thereby connecting anabolic fatty acid synthesis with the oxidation of carbon fuels.
Data availability
The data have been deposited to the ProteomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019) partner repository. The code used to process these data is available at Github https://github.com/j-berg/nowinski_2020.Sequencing data have been deposited at the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession number GSE148617
-
Mitochondrial fatty acid synthesis coordinates mitochondrial oxidative metabolismNCBI Gene Expression Omnibus, GSE148617.
Article and author information
Author details
Funding
National Institute of General Medical Sciences (GM115174)
- Jared Rutter
National Cancer Institute (R35CA22044901)
- Ralph J DeBerardinis
The Once Upon a Time Foundation
- Ralph J DeBerardinis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (F32HD096786)
- Ashley Solmonson
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107397)
- Katsuhiko Funai
National Institute of Diabetes and Digestive and Kidney Diseases (R21AG063077)
- Katsuhiko Funai
Office of the Director (S10OD016232)
- James E Cox
Office of the Director (S10OD021505)
- James E Cox
National Institute of Diabetes and Digestive and Kidney Diseases (U54DK110858)
- James E Cox
National Institute of General Medical Sciences (R01GM132129)
- Joao A Paulo
National Institute of General Medical Sciences (GM97645)
- Steven P Gygi
National Institute of General Medical Sciences (GM115129)
- Jared Rutter
National Institute of General Medical Sciences (GM110755)
- Dennis R Winge
The Nora Eccles Treadwell Foundation
- Jared Rutter
Howard Hughes Medical Institute (Investigator)
- Jared Rutter
United Mitochondrial Disease Foundation (PF-15-046)
- Sara M Nowinski
American Cancer Society (PF-18-106-01)
- Sara M Nowinski
National Heart, Lung, and Blood Institute (T32HL007576)
- Sara M Nowinski
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK11096601)
- Jordan A Berg
Howard Hughes Medical Institute (Investigator)
- Ralph J DeBerardinis
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Peter Tontonoz, University of California, Los Angeles, United States
Version history
- Received: April 20, 2020
- Accepted: August 15, 2020
- Accepted Manuscript published: August 17, 2020 (version 1)
- Version of Record published: September 3, 2020 (version 2)
Copyright
© 2020, Nowinski et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 11,050
- Page views
-
- 1,428
- Downloads
-
- 52
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
Apoptosis signal-regulating kinase 1 (ASK1) is a crucial stress sensor, directing cells toward apoptosis, differentiation, and senescence via the p38 and JNK signaling pathways. ASK1 dysregulation has been associated with cancer and inflammatory, cardiovascular, and neurodegenerative diseases, among others. However, our limited knowledge of the underlying structural mechanism of ASK1 regulation hampers our ability to target this member of the MAP3K protein family towards developing therapeutic interventions for these disorders. Nevertheless, as a multidomain Ser/Thr protein kinase, ASK1 is regulated by a complex mechanism involving dimerization and interactions with several other proteins, including thioredoxin 1 (TRX1). Thus, the present study aims at structurally characterizing ASK1 and its complex with TRX1 using several biophysical techniques. As shown by cryo-EM analysis, in a state close to its active form, ASK1 is a compact and asymmetric dimer, which enables extensive interdomain and interchain interactions. These interactions stabilize the active conformation of the ASK1 kinase domain. In turn, TRX1 functions as a negative allosteric effector of ASK1, modifying the structure of the TRX1-binding domain and changing its interaction with the tetratricopeptide repeats domain. Consequently, TRX1 reduces access to the activation segment of the kinase domain. Overall, our findings not only clarify the role of ASK1 dimerization and inter-domain contacts but also provide key mechanistic insights into its regulation, thereby highlighting the potential of ASK1 protein-protein interactions as targets for anti-inflammatory therapy.
-
- Biochemistry and Chemical Biology
Activation of the extracellular signal-regulated kinase-2 (ERK2) by phosphorylation has been shown to involve changes in protein dynamics, as determined by hydrogen-deuterium exchange mass spectrometry (HDX-MS) and NMR relaxation dispersion measurements. These can be described by a global exchange between two conformational states of the active kinase, named ‘L’ and ‘R,’ where R is associated with a catalytically productive ATP-binding mode. An ATP-competitive ERK1/2 inhibitor, Vertex-11e, has properties of conformation selection for the R-state, revealing movements of the activation loop that are allosterically coupled to the kinase active site. However, the features of inhibitors important for R-state selection are unknown. Here, we survey a panel of ATP-competitive ERK inhibitors using HDX-MS and NMR and identify 14 new molecules with properties of R-state selection. They reveal effects propagated to distal regions in the P+1 and helix αF segments surrounding the activation loop, as well as helix αL16. Crystal structures of inhibitor complexes with ERK2 reveal systematic shifts in the Gly loop and helix αC, mediated by a Tyr-Tyr ring stacking interaction and the conserved Lys-Glu salt bridge. The findings suggest a model for the R-state involving small movements in the N-lobe that promote compactness within the kinase active site and alter mobility surrounding the activation loop. Such properties of conformation selection might be exploited to modulate the protein docking interface used by ERK substrates and effectors.